Merck
MRK
#42
Rank
NZ$615.21 B
Marketcap
NZ$249.36
Share price
-1.43%
Change (1 day)
63.66%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$2.14

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$2.26. In 2025 the company made an earnings per share (EPS) of NZ$13.04 an increase over its 2024 EPS that were of NZ$12.06.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.14-83.55%
2025NZ$13.048.15%
2024NZ$12.064308.46%
2023NZ$0.27-97.32%
2022NZ$10.2210.92%
2021NZ$9.2184.68%
2020NZ$4.99-27.2%
2019NZ$6.8563.44%
2018NZ$4.19151.11%
2017NZ$1.67-54.58%
2016NZ$3.6830.21%
2015NZ$2.82-61.99%
2014NZ$7.43180.51%
2013NZ$2.65-31.82%
2012NZ$3.886.62%
2011NZ$3.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.58 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.88 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.56 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.30 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.93 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.39 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.10 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.70 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.12-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel